Families and the Public

Bubble CPAP therapy opportunity in developing countries

Bubble CPAP therapy opportunity in developing countries

Introduction

In many parts of the world, access to quality healthcare is limited. This is especially true for infant care in developing countries. Bubble Continuous Positive Airway Pressure (BCPAP) is a potentially life-saving technology that can be used to treat respiratory distress in newborns. Bubble CPAP is a treatment that uses gentle pressure to keep the airways open. It is used to treat sleep apnea and other breathing disorders.

Bubble CPAP Low-cost Therapy

Bubble CPAP works by delivering a gentle stream of air to the infant through nasal prongs or nasal mask. This air pressure helps to keep the baby’s airway open, allowing them to breathe more easily. Bubble CPAP is a simple, low-cost technology that can be easily operated by trained personnel. In many developing countries, infant mortality rates are high due to a lack of access to quality healthcare.  Bubble CPAP can be a life-saving intervention for infants suffering from respiratory distress. This technology is simple to use and relatively low-cost, making it an ideal solution for resource-limited settings.   The idea behind Bubble CPAP is simple. An air compressor is used to generate a flow of air through the respiratory tubes that are connected to the nasal prongs or mask. The other end of the respiratory tubes is immersed under the water surface. The bubbles generated under water surface from the airflow produced high frequency low amplitude waves that help in opening the infant’s lung. The air pressure within the circuit keeps the airway open and prevents it from collapsing. Bubble CPAP has been shown to be effective in treating mild to moderate respiratory disorders. Bubble CPAP is an affordable, effective, and easy-to-use therapy for respiratory disorders. It can be used in both developed and developing countries and is a great option for those who cannot afford expensive machines.  

Effect of Bubble CPAP treatment on the mortality rate of infants with respiratory distress

Bubble CPAP has been shown to be effective in reducing mortality and morbidity in infants with respiratory distress. Bubble CPAP is often used as the first line of treatment for respiratory distress in infants and can be used in conjunction with other treatments such as oxygen therapy.  A study in Nepal showed that using bubble CPAP reduced the mortality rate of infants with respiratory distress from 24% to 8%. The use of bubble CPAP also reduced the need for intubation and mechanical ventilation. Bubble CPAP is a simple, life-saving intervention that can be used to treat respiratory distress in infants. It is a low-cost, easy-to-use device that can be used in resource-poor settings. Bubble CPAP has been shown to be effective in reducing mortality and morbidity in infants with respiratory distress. To learn more about the global use of BCPAP treatment around the globe click here

Start exploring our learning modules in bCPAP.

The Bubble CPAP Institute is an interactive educational platform aiming to make the knowledge and skill set of Bubble CPAP accessible to practitioners who care for neonates and young infants across the globe. This platform will primarily focus on the know-how and will offer educational modules on issues like when to consider bCPAP in managing infants with respiratory distress, how to assemble the bCPAP circuits, how to apply the nasal interface and how to troubleshoot bedside issues.

Read modules